Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecasin for Amyotrophic Lateral Sclerosis (ALS) – Phase IIa Double-Blind Placebo-Controlled Trial
KCT0008385Phase 2Recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mecasin in amyotrophic lateral sclerosis (ALS), sponsored by Ministry of Health & Welfare. Started Dec 2018; status: recruiting.
02
Drugs
Mecasin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on KCT0008385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008385.